Operating Lease, Right-of-Use Asset of Achilles Therapeutics plc from 31 Dec 2020 to 30 Jun 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Achilles Therapeutics plc quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2020 to 30 Jun 2024.
  • Achilles Therapeutics plc Operating Lease, Right-of-Use Asset for the quarter ending 30 Jun 2024 was $4,165,000, a 50% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Achilles Therapeutics plc Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $4,165,000 -$4,208,000 -50% 30 Jun 2024 6-K 14 Aug 2024 2024 Q2
Q4 2023 $4,372,000 -$3,709,000 -46% 31 Dec 2023 6-K 14 Aug 2024 2024 Q2
Q2 2023 $8,373,000 30 Jun 2023 6-K 04 Aug 2023
Q4 2022 $8,081,000 -$2,967,000 -27% 31 Dec 2022 20-F 04 Apr 2024 2023 FY
Q4 2021 $11,048,000 -$3,692,000 -25% 31 Dec 2021 20-F 07 Mar 2023 2022 FY
Q4 2020 $14,740,000 31 Dec 2020 20-F 01 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.